Vestis Corp (VSTS) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-07-03..
- Stock-based compensation / revenue · 12 months: Value 0.35%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-03..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.35% | Share-based compensation / revenue. Period ending 2026-07-03. $9.56M ÷ $2.70B × 100 ≈ 0.35% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.70B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 9.56M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 98.25M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-03 | (m) | $2.70B | $9.56M | $98.25M | (m) | (m) | 0.35% | (m) | (m) |
| 2026-04-03 | (m) | $2.71B | $4.13M | $85.96M | (m) | (m) | 0.15% | (m) | (m) |
| 2026-01-02 | (m) | $2.71B | $8.73M | $50.61M | (m) | (m) | 0.32% | (m) | (m) |
| 2025-10-03 | (m) | $2.73B | $11.56M | $64.43M | (m) | (m) | 0.42% | (m) | (m) |
| 2025-06-27 | (m) | $2.71B | $14.04M | $76.57M | (m) | (m) | 0.52% | (m) | (m) |
| 2025-03-28 | (m) | $2.73B | $20.05M | $89.13M | (m) | (m) | 0.73% | (m) | (m) |
| 2024-12-27 | (m) | $2.77B | $16.80M | $140.75M | (m) | (m) | 0.61% | (m) | (m) |
| 2024-09-27 | (m) | $2.81B | $16.34M | $157.95M | (m) | (m) | 0.58% | (m) | (m) |
| 2024-06-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-29 | (m) | $2.83B | $14.47M | $217.91M | (m) | (m) | 0.51% | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $2.69B | $17.40M | $192.24M | (m) | (m) | 0.65% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDUCATIONAL DEVELOPMENT CORP (EDUC) | United States | $0.011B | |
| NATURAL HEALTH TRENDS CORP (NHTC) | United States | $0.009B | |
| HYDROFARM HOLDINGS GROUP, INC. (HYFM) | United States | $0.005B | -0.01 |